Archive for Pharmaceutical Research

From simply using natural substances and plant extracts for the treatment of diseases to systematic and extensive research processes, the pharmaceutical research and development services industry has, indeed, evolved tremendously. The demand for fast and effective medications and drugs, especially for contagious diseases that did not have cure then, paved the way for this fast evolution.

The pharmaceutical industry is responsible for the development of new drugs and medicines that aim to address the different health issues and diseases that the world is facing. And although drug development has been evident since the early times, it was only during the 19th century that the pharmaceutical industry started to use the modern processes of developing and introducing medications to the market.

Today, research and development in the pharmaceutical industry involves high-end equipment and revolutionary procedures. A drug would have to undergo a series of processes and tests, including toxicology, metabolic studies, and pre-clinical pharmacology, before it could be ready for human trial and eventually for introduction to the market. It is a trial-and-error methodology, but with this complicated and extensive endeavor, the industry is able to produce the most effective and safest medication to treat different human diseases.

The world’s continuous battle against many health issues, along with the discovery of new illnesses, has made the role of the pharmaceutical industry challenging and critical. And while the success of pharmaceutical research and development lies on the availability of resources, including excellent scientific talents and knowledgeable individuals, the success of the pharmaceutical industry depends on adequate research and development.

Resource Box:

UPM Pharmaceuticals is a leading provider of pharmaceutical research and development services. The company also offers formulation development, stability testing and analytical methods of development, among other services. For more information, visit www.upm-inc.com or call 410-843-3738.

Jeff Paul is a writer and copy editor who likes to share information on many different topics.

Categories : Trials
Comments (0)


This video highlights some of the remarks made by participants at the opening of the experts meeting on the first-ever comprehensive study on African pharmaceutical research and development capacity: Strengthening Pharmaceutical Innovation in Africa. Significantly, the meeting received strong support from several senior African political figures Dr. Ibrahim Assane Mayaki, Chief Executive Officer of The New Partnership for Africas Development (NEPAD) Planning and Coordinating Agency (NPCA); Naledi Pandor, South Africas Minister of Science and Technology, and AU Social Affairs Commissioner Bience Gawanas. They applauded the practical steps that the group proposed for African medicines innovation, which will help put into action the emerging innovation and finding mechanisms for countries medicines priorities the Pharmaceutical Manufacturing Plan for Africa and Global Strategy and Plan of Action on Public, Innovation and Intellectual Property. This video clip highlights the remarks made by Carel ijsselmuiden, Director of Council on Health Research for Development (COHRED)

Categories : Trials
Comments (0)

This is what they don’t want the American people to know….

THE BAYH DOYLE ACT THE FIRST STEP TOWARDS COMMERCIALIZATION
This Act that Reagan introduced was intended to encourage the spreading of pharmaceutical education so that universities and the odd small business could patent the scientific discoveries from pharmaceutical research.

So, the public would pay for research that would ultimately serve the public’s health interest, in an industry that instantly became private. Our money then would now go to these big pharmaceutical companies instead of to improving the health of the American people.

The Bayh Doyle Act then has resulted in making the pharmaceuticals industry a $200 billion dollar industry every year. These are now the richest companies in the world.

And this has effectively changed the manner in which pharmaceutical education is disseminated. Now clinical trials are more biased than ever before, non-reporting of actual results is not happening, and the education behind real time data is being obscured and muddied. This is really happening people!

WHERE ARE YOUR DRUG DOLLARS GOING?
But wait, there is more. The government is behind all of it. In fact, the pharmaceutical industry is the largest lobbying body in Washington as we speak.

In 2002, the pharmaceutical industry employed almost 700 lobbyists, 26 of whom were former Congressmen, to lobby the government for higher costs in Medicare and more profits for the pharmaceutical industry.

That effort alone cost the taxpayers $91 million dollars alone, not to mention the challenges that the increased costs of Medicare incurred on the average American.

The corruption and scandal that lies behind the doors of the pharmaceutical industry is the education this country really needs, not the propaganda that we are paying for them to spit out.

I like to keep people informed of things like this, because the naysayers in this section work for and are paid by these same companies that try to keep us stupid. Their big money profits depend on keeping you and I in the dark.

We are taking back AMERICA! and not gonna take it anymore! You can believe that!
Hey Round 2, Little do you know that the pharmaceutical companies big money also finds it’s place in the lawyers pockets also. People need to open their eyes because I can see by comments like this that people just don’t KNOW!

Categories : Trials
Comments (7)


Product Description
This biographical collection highlights individuals who made outstanding achievements in the arenas of pharmaceuticals and biotechnology. Pharmaceutical Achievers presents chronologically the major directions of pharmaceutical research and, in their historical context, the breakthroughs in treating various diseases. It concludes with a look at tomorrow’s medicines. This work is particularly useful in the classroom, where its accounts of challenges and triumphs may inspire students to consider careers that support pharmaceutical research and development.
Pharmaceutical Achievers: The Human Face of Pharmaceutical Research

Categories : Trials
Comments (0)


Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: PhRMA code tightens limits on gift giving. (Hailed by consumer, Medical Groups).(Pharmaceutical Research and Manufacturers of America)
Author: Diana Mahoney
Publication: Skin & Allergy News (Magazine/Journal)
Date: August 1, 2002
Publisher: International Medical News Group
Volume: 33 Issue: 8 Page: 46(1)

Distributed by Thomson Gale
PhRMA code tightens limits on gift giving. : An article from: Skin & Allergy News

Categories : Trials
Comments (0)


Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: PhRMA code tightens limits on gift giving. (Hailed by consumer, Medical Groups).(Pharmaceutical Research and Manufacturers of America)
Author: Diana Mahoney
Publication: Skin & Allergy News (Magazine/Journal)
Date: August 1, 2002
Publisher: International Medical News Group
Volume: 33 Issue: 8 Page: 46(1)

Distributed by Thomson Gale
PhRMA code tightens limits on gift giving. : An article from: Skin & Allergy News

Categories : Trials
Comments (0)


Product Description
This digital document is a journal article from Social Science & Medicine, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
Most critiques of evidence-based medicine (EBM) focus on the scientific shortcomings of the technique. Social scientists are more likely to criticize EBM for it ideological biases, a criticism that makes sociological sense but is difficult to substantiate. Using data from our studies of (1) the influence of pharmaceutical companies on the conduct and reporting of clinical trials, and (2) obstetric science in the Netherlands (where nearly one-third of births occur at home) we show how the evidence of evidence-based medicine is shaped by forces both structural and cultural. The threats to objective evidence are many, and, if EBM is to be true to its own principles, it must take these threats into account.
The social and cultural shaping of medical evidence: Case studies from pharmaceutical research and obstetric science

Categories : Trials
Comments (0)


Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: PhRMA code tightens limits on gift giving. (Hailed by consumer, Medical Groups).(Pharmaceutical Research and Manufacturers of America)
Author: Diana Mahoney
Publication: Skin & Allergy News (Magazine/Journal)
Date: August 1, 2002
Publisher: International Medical News Group
Volume: 33 Issue: 8 Page: 46(1)

Distributed by Thomson Gale
PhRMA code tightens limits on gift giving. : An article from: Skin & Allergy News

Categories : Trials
Comments (0)


Product Description

AllPosters.com is the world’s #1 seller of posters, prints, photographs, specialty products and framed art. We’re dedicated to bringing our customers the best selection of high quality wall décor that is perfect for their home or office. Browse our catalog of over 300,000 items that include entertainment and specialty posters, decorative prints, and art reproductions. Whether you’re looking for your favorite movie or music poster, a framed Monet reproduction, or a print of the Eiffel Tower you will find it at AllPosters.com. Visit our Amazon store today at www.amazon.com/allposters to find Special Offers and search by subject category or artist. AllPosters.com provides unmatched service with a 100% satisfaction guarantee. We ship internationally to over 80 countries. Decorate your home today with your favorite pictures.
Image of Doctor Beside Pharmaceutical Research Photographic Poster Print, 40×30

Categories : Trials
Comments (0)


Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: PhRMA code tightens limits on gift giving. (Hailed by consumer, Medical Groups).(Pharmaceutical Research and Manufacturers of America)
Author: Diana Mahoney
Publication: Skin & Allergy News (Magazine/Journal)
Date: August 1, 2002
Publisher: International Medical News Group
Volume: 33 Issue: 8 Page: 46(1)

Distributed by Thomson Gale
PhRMA code tightens limits on gift giving. : An article from: Skin & Allergy News

Categories : Trials
Comments (0)